Role of benefit-risk assessment and pharmacoeconomics in decision-making of medicines
OBJECTIVESThis course gives you an introduction about the role of benefit-risk assessment and pharmacoeconomics in decision-making of medicines. It provides insight in the changing health care environment and gives an overview of the different stakeholders that are involved in pharmacotherapeutic decision-making. Specific attention is given to the drivers and background of the different stakeholders and the rationale of benefit/risk and pharmacoeconomic evaluations in decision-making.
LEARNING OUTCOMESAt the end of this course, you will:
|
|
AUTHORS
Prof. Olaf Klungel Universiteit Utrecht |
Prof. Jan A.m. Raaijmakers GlaxoSmithKline Research and Development Ltd |
Prof. Hubert Leufkens Universiteit Utrecht |
Dr. George Quartey F. Hoffmann-La Roche Ltd |